TRADING UPDATES: Genflow patent progress; Accsys new debt facilities
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 7.23p on 27-10-2025 at 06:00:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Sell 3,362.00 at 7.23p |
| Day's Volume: | 0 |
| Last Close: | 7.23p |
| Open: | 0.00p |
| ISIN: | GB00BNTXR104 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 5.875p - 64.50p |
| Market Capitalisation: | £5.15m |
| VWAP: | 0.00p |
| Shares in Issue: | 71.23m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Tissue Regenix Group (TRX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 3,362 | 7.23p | Ordinary |
13:24:46 - 22-Oct-25 |
| Buy* | 21 | 7.50p | SI Trade |
13:24:43 - 22-Oct-25 |
| Buy* | 200 | 7.50p | SI Trade |
13:24:43 - 22-Oct-25 |
| Sell* | 900 | 7.00p | SI Trade |
13:24:43 - 22-Oct-25 |
| Buy* | 13 | 7.50p | SI Trade |
13:24:43 - 22-Oct-25 |
| Buy* | 426 | 7.50p | SI Trade |
13:24:43 - 22-Oct-25 |
| Sell* | 57 | 7.00p | SI Trade |
13:24:43 - 22-Oct-25 |
| Sell* | 206 | 7.00p | SI Trade |
13:24:43 - 22-Oct-25 |
| Buy* | 1,000 | 7.50p | SI Trade |
13:24:43 - 22-Oct-25 |
| Sell* | 149 | 7.00p | SI Trade |
13:24:43 - 22-Oct-25 |
Tissue Regenix Group (TRX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Oct 2025 3:29 pm | RNS | Statement re. Suspension |
| 22nd Oct 2025 2:02 pm | RNS | Suspension - Tissue Regenix Group PLC |
| 17th Oct 2025 7:00 am | RNS | CFO joins Board |
| 16th Oct 2025 7:00 am | RNS | Update re. FY24 & H125 restatement & Board Changes |
| 9th Oct 2025 7:00 am | RNS | Holding(s) in Company |
| 6th Oct 2025 3:29 pm | RNS | Holding(s) in Company |
| 3rd Oct 2025 3:01 pm | RNS | Holding(s) in Company |
| 2nd Oct 2025 4:43 pm | RNS | Holding(s) in Company |
| 1st Oct 2025 5:35 pm | RNS | Holding(s) in Company |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |